Page last updated: 2024-09-03

umifenovir and Disease Exacerbation

umifenovir has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Cleland, E; Giovane, RA; Henderson, CE; Rezai, S	1
Keykhaei, M; Mansouri, ES; Rahimzadeh, H; Razeghi, E; Zivari, E	1
Aleksandrov, AL; Kovaleva, LF; Kozyrev, AG; Kulikov, VD; Kuzubova, NA; Petrova, MA; Shklyarevich, NA; Titova, ON	1

Reviews

1 review(s) available for umifenovir and Disease Exacerbation

Article	Year
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review. Reviews in medical virology, 2020, Volume: 30, Issue:5 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Drug Repositioning; Esters; Gabexate; Gene Expression Regulation; Guanidines; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2020

Article

Year

Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.

Reviews in medical virology, 2020, Volume: 30, Issue:5

Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Drug Repositioning; Esters; Gabexate; Gene Expression Regulation; Guanidines; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus

2020

Other Studies

2 other study(ies) available for umifenovir and Disease Exacerbation

Article	Year
COVID-19 progression in kidney transplant recipients: a single-center case series. CEN case reports, 2021, Volume: 10, Issue:4 Topics: Acute Kidney Injury; Adult; Antimalarials; Antiviral Agents; COVID-19; Disease Progression; Female; Glucocorticoids; Hospital Mortality; Humans; Hydroxychloroquine; Immunosuppressive Agents; Indoles; Intensive Care Units; Iran; Kidney Transplantation; Male; Middle Aged; Outcome Assessment, Health Care; Prednisolone; Risk Factors; SARS-CoV-2; Transplant Recipients	2021
Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease. Terapevticheskii arkhiv, 2018, Aug-27, Volume: 90, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Asthma; Disease Progression; Humans; Indoles; Influenza, Human; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Young Adult	2018

Article

Year

COVID-19 progression in kidney transplant recipients: a single-center case series.

CEN case reports, 2021, Volume: 10, Issue:4

Topics: Acute Kidney Injury; Adult; Antimalarials; Antiviral Agents; COVID-19; Disease Progression; Female; Glucocorticoids; Hospital Mortality; Humans; Hydroxychloroquine; Immunosuppressive Agents; Indoles; Intensive Care Units; Iran; Kidney Transplantation; Male; Middle Aged; Outcome Assessment, Health Care; Prednisolone; Risk Factors; SARS-CoV-2; Transplant Recipients

2021

Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease.

Terapevticheskii arkhiv, 2018, Aug-27, Volume: 90, Issue:8

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Asthma; Disease Progression; Humans; Indoles; Influenza, Human; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Young Adult

2018